Ir Biosciences Holdings Inc (IRBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,110 | -1,220 | -5,460 | -4,410 | -1,970 |
| Depreciation Amortization | 90 | 40 | 10 | 9 | 6 |
| Other Working Capital | -200 | -220 | 500 | 290 | 170 |
| Other Operating Activity | 60 | 60 | 2,500 | 2,291 | 564 |
| Operating Cash Flow | $-2,160 | $-1,340 | $-2,450 | $-1,820 | $-1,230 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -2 | -20 | -7 | -8 |
| Investing Cash Flow | $-2 | $-2 | $-20 | $-7 | $-8 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 2,750 | 1,820 | -50 | -50 | 0 |
| Financing Cash Flow | $2,750 | $1,820 | $-50 | $-50 | $0 |
| Beginning Cash Position | 220 | 220 | 2,750 | 2,750 | 2,750 |
| End Cash Position | 810 | 690 | 220 | 870 | 1,510 |
| Net Cash Flow | $590 | $470 | $-2,530 | $-1,880 | $-1,230 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,160 | -1,340 | -2,450 | -1,820 | -1,230 |
| Free Cash Flow | -2,160 | -1,340 | -2,450 | -1,820 | -1,230 |